Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
Alena Cristina Jaime‐Ramirez(The Ohio State University), Matthew Old, Robert A. Baiocchi(The Ohio State University Wexner Medical Center), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Enrico Caserta(City of Hope), Craig C. Hofmeister(The Ohio State University), Bhavna Kumar(Dehradun Institute of Technology University), Balveen Kaur(Augusta University), Pawan Kumar(The Ohio State University), Jianying Zhang(Shanxi Agricultural University), Quintin Pan(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Flavia Pichiorri(City Of Hope National Medical Center), Jun-Ge Yu(The Ohio State University Wexner Medical Center), Tae Jin Lee(Augusta University), Theodoros N. Teknos(University Hospitals Seidman Cancer Center), John H. Lee(Beth Israel Deaconess Medical Center)
Cited by 40
Related Papers
Guidelines for the use and interpretation of assays for monitoring autophagy
|Autophagy|2012|4.1k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
|Cancer Cell|2014|1k
Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer
|International Journal of Radiation Oncology*Biology*Physics|2002|508